In a recent study published in Cytokine & Growth Factor Reviews, researchers discussed the development of messenger ribonucleic acid (mRNA) vaccines against the respiratory syncytial virus (RSV).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback